Key facts
- This page summarizes PURA VIDA INVESTMENTS, LLC's Form 4 filing for MedMen Enterprises, Inc..
- 8 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 29 Apr 2022, 16:41.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Expiration (or cancellation) of long derivative position with value received
Expiration (or cancellation) of long derivative position with value received
Expiration (or cancellation) of long derivative position with value received
Expiration (or cancellation) of long derivative position with value received
Expiration (or cancellation) of long derivative position with value received
Expiration (or cancellation) of long derivative position with value received
Expiration (or cancellation) of long derivative position with value received
Expiration (or cancellation) of long derivative position with value received
Additional SEC filing notes
Footnote F1
On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").
Footnote F2
Currently exercisable.
Footnote F3
Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.
Footnote F4
The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.
Footnote F5
This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.